Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|November 13, 2014
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE studyAtul Deodhar, Jürgen Braun, Robert D Inman, et al.
Frontiers in Public Health|June 5, 2023
Social capital and loneliness among older adults in community dwellings and nursing homes in Zhejiang Province of ChinaYan Chen, Yuchen Zhou, Min Li, et al.
Annals of the Rheumatic Diseases|July 31, 2013
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER studyJosef S Smolen, Jonathan Kay, Eric L Matteson, et al.
Enzyme and Microbial Technology|December 18, 2018
Convenient preparation of sagittatoside B, a rare bioactive secondary flavonol glycoside, by recyclable and integrated biphase enzymatic hydrolysisYuping Shen, Man Wang, Yufei Chen, et al.
Molecular Neurobiology|December 14, 2024
Light Treatment Ameliorates Sub-chronic MK-801-Induced Cognitive Deficits in Mice Through Up-regulating BDNF/p-CREB/p-ERK Signaling PathwayKeke Cui, Yiying Zhou, Lizhi Zhang, et al.
Frontiers in Aging Neuroscience|December 17, 2021
Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer's DiseaseLe Xu, Yiying Zhou, Linbo Hu, et al.
Arthritis Research & Therapy|March 22, 2022
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisM Elaine Husni, Atul Deodhar, Sergio Schwartzman, et al.
Metabolic Brain Disease|January 10, 2020
Edaravone at high concentrations attenuates cognitive dysfunctions induced by abdominal surgery under general anesthesia in aged miceYiying Zhou, Xiang Wu, Luying Ye, et al.
Annals of the Rheumatic Diseases|May 7, 2013
The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trialJürgen Braun, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Frontiers in Molecular Neuroscience|September 29, 2022
A comparison of reinforcing effectiveness and drug-seeking reinstatement of 2-fluorodeschloroketamine and ketamine in self-administered ratsHan Du, Miaojun Lai, Dingding Zhuang, et al.
Pageof 5